KCM
DBD

Kennedy Capital Management’s Diebold Nixdorf Incorporated DBD Stock Holding History

Kennedy Capital Management’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-119,562
Closed -$170K – 653
2022
Q4 		$170K Sell
119,562
-6,472
-5% -$13.9K ﹤0.01% 600
2022
Q3 		$308K Buy
126,034
+1,036
+0.8% +$3.46K 0.01% 576
2022
Q2 		$284K Sell
124,998
-652,067
-84% -$2.43M 0.01% 574
2022
Q1 		$5.23M Sell
777,065
-4,786
-0.6% -$40.9K 0.12% 290
2021
Q4 		$7.08M Sell
781,851
-14,154
-2% -$132K 0.15% 256
2021
Q3 		$8.05M Buy
796,005
+73,785
+10% +$809K 0.18% 203
2021
Q2 		$9.27M Buy
722,220
+52,363
+8% +$718K 0.2% 184
2021
Q1 		$9.46M Sell
669,857
-17,364
-3% -$239K 0.19% 192
2020
Q4 		$7.33M Buy
687,221
+215,614
+46% +$1.96M 0.17% 228
2020
Q3 		$3.6M Buy
+471,607
New +$3.47M 0.1% 372

Other funds holding DBD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kennedy Capital Management's DBD Position: Q1 2023 in Review

Kennedy Capital Management sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2023, closing a stake of 119,562 shares — an estimated $170K sold.

Kennedy Capital Management first reported a position in DBD in Q3 2020 and held it in 10 quarters. The position peaked at $9.46M in Q1 2021. 128 funds tracked by Wall St. Rank hold DBD as of Q1 2023.

  • Kennedy Capital Management reported no remaining Diebold Nixdorf Incorporated position as of Q1 2023 after selling out during the quarter.
  • Kennedy Capital Management sold 119,562 Diebold Nixdorf Incorporated shares in Q1 2023, an estimated $170K.
  • Kennedy Capital Management first reported a position in Diebold Nixdorf Incorporated in Q3 2020 and held it in 10 quarters.
  • Kennedy Capital Management's Diebold Nixdorf Incorporated position peaked at $9.46M in Q1 2021.
  • 128 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2023.

Based on Kennedy Capital Management's 13F filing for Q1 2023, filed 15 May 2023.